DD: Newron Pharmaceuticals S.p.A.: Dr. Ulrich Köstlin, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.06.2024 / 09:52 CET/CEST The issuer is solely responsible for the content of this announcement. 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: Dr. First name: Ulrich Last name(s): Köstlin 2. Reason for the notification a) Position / status Position: Member of the administrative or supervisory body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Newron Pharmaceuticals S.p.A. b) LEI 8156002F8C11F80A9740  4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: IT0004147952 b) Nature of the transaction Acquisition c) Price(s) and volume(s) Price(s) Volume(s) 9.8 CHF 12955.6 CHF 9.8 CHF 9800 CHF 9.8 CHF 4900 CHF 9.8 CHF 1009.4 CHF d) Aggregated information Price Aggregated volume 9.8000 CHF 28665.0000 CHF e) Date of the transaction 17/06/2024; UTC+2 f) Place of the transaction Name: SIX Swiss Exchange MIC: XSWX 18.06.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

Language:	English
Company:	Newron Pharmaceuticals S.p.A.
	via Antonio Meucci 3
	20091 Bresso
	Italy
Internet:	www.newron.com

End of News	EQS News Service

92487  18.06.2024 CET/CEST